Want to see FR:ALAFY full AI Analyst Report?
AFYREN (ALAFY) AI Stock Analysis
AFYREN
(Paris:ALAFY)
The score is driven primarily by weak financial performance—shrinking revenue, deep losses, and persistent cash burn—partly cushioned by a relatively strong, low-debt balance sheet. Technical indicators also lean bearish with the stock trading below key moving averages and negative MACD. Valuation provides limited support because earnings are negative and there is no dividend yield provided.
AFYREN (ALAFY) vs. iShares MSCI France ETF (EWQ)
- Market Cap
- EUR 87.81M
- Dividend Yield
- ―
- Average Volume (3M)
- 11.60K
- Price to Earnings (P/E)
- -11.4
- Beta (1Y)
- 0.04
- Revenue Growth
- -13.62%
- EPS Growth
- 54.46%
- Country
- France
- Employees
- 149
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
AFYREN Business Overview & Revenue Model
Company Description
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubric...
How the Company Makes Money
AFYREN makes money primarily by selling bio-based organic acids produced via its proprietary fermentation technology and associated downstream purification at industrial scale. The company’s core revenue model is product sales: it supplies customers...
AFYREN Financial Statement Overview
Summary
Overall fundamentals are weak due to declining revenue, sharply negative profitability (including a large gross loss in 2025), and consistently negative operating/free cash flow. The main offset is a comparatively stronger balance sheet with materially reduced debt and low leverage, which provides some financial flexibility despite ongoing losses.
Income Statement
18Very NegativeBalance Sheet
62PositiveCash Flow
24Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.33M | 2.27M | 2.86M | 3.38M | 3.46M | 3.04M |
| Gross Profit | -10.71M | -5.49M | -174.00K | 645.00K | 1.06M | 1.47M |
| EBITDA | -11.42M | -6.81M | -8.81M | -8.59M | -4.71M | -2.78M |
| Net Income | -5.01M | -14.37M | -9.75M | -9.59M | -9.20M | -3.61M |
Balance Sheet | ||||||
| Total Assets | 139.25M | 67.14M | 58.56M | 70.43M | 84.82M | 93.15M |
| Cash, Cash Equivalents and Short-Term Investments | 17.30M | 35.16M | 33.65M | 49.66M | 62.40M | 67.36M |
| Total Debt | 40.90M | 2.42M | 3.31M | 4.79M | 8.54M | 8.95M |
| Total Liabilities | 67.49M | 4.19M | 5.86M | 8.63M | 13.84M | 15.29M |
| Stockholders Equity | 71.76M | 62.10M | 52.70M | 61.80M | 70.98M | 77.86M |
Cash Flow | ||||||
| Free Cash Flow | -15.31M | -5.29M | -5.84M | -5.60M | -3.83M | -3.06M |
| Operating Cash Flow | -9.84M | -5.09M | -5.62M | -5.04M | -3.30M | -2.71M |
| Investing Cash Flow | -27.49M | -15.25M | -9.11M | -3.08M | -362.00K | -436.00K |
| Financing Cash Flow | 27.17M | 21.96M | -1.28M | -4.66M | -1.14M | 60.77M |
AFYREN Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALAFY, the sentiment is Negative. The current price of 2.26 is below the 20-day moving average (MA) of 2.29, below the 50-day MA of 2.51, and below the 200-day MA of 2.68, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 42.54 is Neutral, neither overbought nor oversold. The STOCH value of 64.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALAFY.
AFYREN Peers Comparison
Overall Rating
FR:AI73Outperform
FR:CBE63Neutral
FR:AKE56Neutral
FR:ALBKK55Neutral
FR:ALCRB46Neutral- FR:ALAFY44.75Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| FR:AI | 73Outperform | EUR 115.22B | 30.98 | 13.42% | 1.69% | -1.30% | 3.05% |
| FR:CBE | 63Neutral | EUR 1.57B | 16.03 | ― | 1.92% | 0.30% | 0.78% |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| FR:AKE | 56Neutral | EUR 4.30B | 329.70 | 0.92% | 6.42% | -5.73% | -73.67% |
| FR:ALBKK | 55Neutral | EUR 74.86M | 45.33 | 3.51% | 1.47% | 6.97% | -73.50% |
| FR:ALCRB | 46Neutral | EUR 87.05M | -4.33 | -10.62% | ― | ― | ― |
| FR:ALAFY | 45Neutral | EUR 87.81M | -11.44 | -7.49% | ― | -13.62% | 54.46% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FR:ALAFY | AFYREN | 2.26 | 0.14 | 6.60% | |
| FR:AI | Air Liquide (UK) | 180.90 | 31.59 | 21.16% | |
| FR:AKE | Arkema SA (UK) | 56.05 | 8.76 | 18.51% | |
| FR:ALCRB | Carbios SA | 5.15 | -1.96 | -27.62% | |
| FR:ALBKK | Baikowski SA | 20.40 | -2.32 | -10.23% | |
| FR:CBE | Robertet SA Cert.d'Invest. Em.87 | 625.00 | -82.39 | -11.65% |
AFYREN Corporate Events
AFYREN’s biosourced propionic acid powers first-of-its-kind skincare launch
AFYREN is reinforcing its role in sustainable industrial biotechnology by supplying 100% biosourced, COSMOS‑certified propionic acid produced via a low‑carbon, circular fermentation process at its AFYREN NEOXY biorefinery in France. The c...
AFYREN and Terrial Renew Multi‑Year Potassium Fertilizer Alliance
AFYREN and Terrial have renewed their strategic partnership with a new multi‑year fertilizer supply contract worth several tens of millions of euros, centered on AFYREN’s potassium‑rich fertilizer processed by Terrial and marketed i...
AFYREN Takes Full Control of Flagship Plant as Production and Pre-Sold Volumes Surge
AFYREN has strengthened its industrial profile by acquiring the remaining 49% of its AFYREN NEOXY plant, becoming its sole owner and gaining full control over ramp-up and performance investments. The company successfully executed an optimization prog...
AFYREN scales bio-based acid output and strengthens climate-resilient positioning
AFYREN has crossed the milestone of 1,000 tonnes of bio-based acids produced at its AFYREN NEOXY biorefinery since ramp-up began in mid-2025, including more than 200 tonnes since operations resumed in July 2026, signalling its transition to full indu...
AFYREN Details Share Capital and Voting Rights Structure as of July 31, 2026
AFYREN, a French greentech company listed on Euronext Growth Paris, develops biobased, low-carbon carboxylic acids through a circular, biomass-based fermentation process aimed at reducing reliance on fossil resources. Its technology serves a broad se...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 17, 2026